BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33128383)

  • 21. Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition.
    Peng L; Jiang D
    PLoS One; 2018; 13(10):e0205918. PubMed ID: 30356255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway.
    Huang L; Huang Z; Lin W; Wang L; Zhu X; Chen X; Yang S; Lv C
    Int J Oncol; 2019 Jun; 54(6):1969-1980. PubMed ID: 31081055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Notoginsenoside R1 protects human keratinocytes HaCaT from LPS-induced inflammatory injury by downregulation of Myd88.
    Zhang J; Zheng Q; Lu H; Jin F; Li Y; Bi F; Xu J
    Int J Immunopathol Pharmacol; 2019; 33():2058738419857550. PubMed ID: 31204533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway.
    Kong G; Jiang Y; Sun X; Cao Z; Zhang G; Zhao Z; Zhao Y; Yu Q; Cheng G
    Oncol Rep; 2017 Nov; 38(5):2647-2656. PubMed ID: 29048621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catalpol suppresses osteosarcoma cell proliferation through blocking epithelial-mesenchymal transition (EMT) and inducing apoptosis.
    Wang L; Xue GB
    Biochem Biophys Res Commun; 2018 Jan; 495(1):27-34. PubMed ID: 29032182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-parvifuran inhibits metastatic and invasive actions through the JAK2/STAT3 pathway in osteosarcoma cells.
    Yun HM; Park KR; Quang TH; Oh H; Hong JT; Kim YC; Kim EC
    Arch Pharm Res; 2017 May; 40(5):601-609. PubMed ID: 28386742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells.
    Han S; Jeong AJ; Yang H; Bin Kang K; Lee H; Yi EH; Kim BH; Cho CH; Chung JW; Sung SH; Ye SK
    J Ethnopharmacol; 2016 Dec; 194():83-90. PubMed ID: 27566200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telocinobufagin inhibits osteosarcoma growth and metastasis by inhibiting the JAK2/STAT3 signaling pathway.
    Ma X; Xu W; Jin X; Mu H; Wang Z; Hua Y; Cai Z; Zhang T
    Eur J Pharmacol; 2023 Mar; 942():175529. PubMed ID: 36690054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.
    Liu W; Long Q; Zhang W; Zeng D; Hu B; Liu S; Chen L
    Aging (Albany NY); 2021 Aug; 13(15):19760-19775. PubMed ID: 34388111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Notoginsenoside R1 protects WI-38 cells against lipopolysaccharide-triggered injury via adjusting the miR-181a/TLR4 axis.
    Qian D; Shao X; Li Y; Sun X
    J Cell Biochem; 2019 Dec; 120(12):19764-19774. PubMed ID: 31297873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells.
    Li MZ; Lai DH; Zhao HB; Chen Z; Huang QX; Situ J
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3005-3011. PubMed ID: 28742207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-6 reverses Adriamycin resistance in nasal NK/T-cell lymphoma via downregulation of ABCC4 and inactivation of the JAK2/STAT3/NF-κB/P65 pathway.
    Gao M; Liu L; Zhang X; Li Z; Zhang M
    Environ Toxicol Pharmacol; 2021 Jul; 85():103639. PubMed ID: 33771682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notoginsenoside R1 attenuates oxidative stress-induced osteoblast dysfunction through JNK signalling pathway.
    Li X; Lin H; Zhang X; Jaspers RT; Yu Q; Ji Y; Forouzanfar T; Wang D; Huang S; Wu G
    J Cell Mol Med; 2021 Dec; 25(24):11278-11289. PubMed ID: 34786818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sesamolin exerts anti-proliferative and apoptotic effect on human colorectal cancer cells via inhibition of JAK2/STAT3 signaling pathway.
    Wu D; Wang XP; Zhang W
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):96-100. PubMed ID: 31472054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A natural product phillygenin suppresses osteosarcoma growth and metastasis by regulating the SHP-1/JAK2/STAT3 signaling.
    Ding X; Lu D; Fan J
    Biosci Biotechnol Biochem; 2021 Feb; 85(2):307-314. PubMed ID: 33604629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of STAT3 Phosphorylation Promotes Apoptosis and Chemosensitivity in Human Osteosarcoma Induced by Raddeanin A.
    Wang Z; Wang C; Zuo D; Zhang T; Yin F; Zhou Z; Wang H; Xu J; Mao M; Wang G; Hua Y; Sun W; Cai Z
    Int J Biol Sci; 2019; 15(3):668-679. PubMed ID: 30745853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Notoginsenoside R1 Promotes Migration, Adhesin, Spreading, and Osteogenic Differentiation of Human Adipose Tissue-Derived Mesenchymal Stromal Cells.
    Wang H; Yan Y; Lan H; Wei N; Zheng Z; Wu L; Jaspers RT; Wu G; Pathak JL
    Molecules; 2022 May; 27(11):. PubMed ID: 35684342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitidine chloride suppresses epithelial-mesenchymal transition and stem cell-like properties in glioblastoma by regulating JAK2/STAT3 signaling.
    Jia M; Wang Y; Guo Y; Yu P; Sun Y; Song Y; Zhao L
    Cancer Med; 2021 May; 10(9):3113-3128. PubMed ID: 33788424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6/JAK2/STAT3 signaling.
    Lu J; Dong Q; Zhang S; Feng Y; Yang J; Zhao L
    Cancer Sci; 2023 Aug; 114(8):3287-3300. PubMed ID: 37272257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway.
    Park KR; Yun HM; Quang TH; Oh H; Lee DS; Auh QS; Kim EC
    Oncotarget; 2016 Feb; 7(6):6960-71. PubMed ID: 26755649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.